|
CDK4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62530000002992E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.236800E-04 |
| Normal-vs-Stage2 |
4.039200E-03 |
| Normal-vs-Stage3 |
1.81020000000753E-06 |
| Normal-vs-Stage4 |
3.55020000000206E-05 |
| Stage1-vs-Stage2 |
3.178600E-01 |
| Stage1-vs-Stage3 |
8.729700E-02 |
| Stage1-vs-Stage4 |
9.764000E-02 |
| Stage2-vs-Stage3 |
8.731400E-01 |
| Stage2-vs-Stage4 |
6.828400E-01 |
| Stage3-vs-Stage4 |
7.144800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05719999998755E-06 |
| Normal-vs-AfricanAmerican |
3.59690000000246E-05 |
| Normal-vs-Asian |
4.393400E-04 |
| Caucasian-vs-AfricanAmerican |
2.407200E-01 |
| Caucasian-vs-Asian |
9.073400E-01 |
| AfricanAmerican-vs-Asian |
4.408400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.356380E-03 |
| Normal-vs-Female |
6.9979999994807E-07 |
| Male-vs-Female |
1.924020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.044100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.0310999999662E-06 |
| Normal-vs-Age(61-80Yrs) |
2.40429999999181E-05 |
| Normal-vs-Age(81-100Yrs) |
3.676200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.023840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.908960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.542800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.449600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.323400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.796000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.721840E-02 |
| Classical-VS-Follicular |
1.192560E-01 |
| Classical-VS-Other |
2.645200E-01 |
| Classical-VS-Normal |
3.14310000026907E-07 |
| Tall-VS-Follicular |
3.118000E-03 |
| Tall-VS-Other |
4.069700E-02 |
| Tall-VS-Normal |
5.88009999580308E-08 |
| Follicular-VS-Other |
8.357800E-01 |
| Follicular-VS-Normal |
6.560300E-02 |
| Other-VS-Normal |
5.959600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.32549999999288E-05 |
| Normal-vs-N1 |
4.514300E-02 |
| N0-vs-N1 |
3.609000E-01 |
|
|
